Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 10Brain Neoplasms 3Urogenital Diseases 2Neoplasms 2Glioblastoma 2Disease 2Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Glioma 1Carcinoma, Lobular 1Breast Neoplasms 1

Interventions

Radiotherapy 3Chemotherapy, Adjuvant 3Magnetic Resonance Spectroscopy 2Letrozole 2Carboplatin 2gallium 68 PSMA-11 1fluciclovine F-18 1atamestane 1Zolpidem 1Venlafaxine Hydrochloride 1Trastuzumab 1Toremifene 1Thiotepa 1Tamoxifen 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Conformal 1Radiosurgery 1Radiation 1Proton Therapy 1Paclitaxel 1Melphalan 1Mass Spectrometry 1Indocyanine Green 1Immunohistochemistry 1Histocompatibility Testing 1Gene Expression Profiling 1Fulvestrant 1Fluorescent Antibody Technique 1Estrogen Receptor Modulators 1Drugs, Generic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Lobular × fluciclovine F-18 × Clear all
NCT04750473 2025-01-17

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Emory University

Phase 1 Completed
20 enrolled 7 charts

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡